Markets:

Overview

News

Currencies

International

Treasuries

Rocket Pharmaceuticals, Inc. - Common Stock (NQ:RCKT)

2.930 +0.090 (+3.17%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rocket Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Analyst Ratings for Rocket Pharmaceuticals ↗

November 07, 2023

Via Benzinga

Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress

November 06, 2023

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Stock Sees Improved Price Strength ↗

November 02, 2023

On Thursday, Rocket Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 68 to 78

Via Investor's Business Daily

Rocket Pharmaceuticals Stock Sees RS Rating Pops Higher ↗

October 27, 2023

A Relative Strength Rating upgrade for Rocket Pharmaceuticals shows improving technical performance. Will it continue?

Via Investor's Business Daily

Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral and AAV Gene Therapies at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

October 19, 2023

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) Near the Top of Equities by Percentage Gain on 9/13

September 13, 2023

Via Investor Brand Network

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 ↗

October 24, 2023

Via Benzinga

Rocket Pharmaceuticals Announces FDA Acceptance of Biologics License Application with Priority Review for RP-L201 (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

October 02, 2023

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Analyst Expectations for Rocket Pharmaceuticals's Future ↗

September 13, 2023

Via Benzinga

Rocket Pharmaceuticals to Participate in the Chardan 7th Annual Genetic Medicines Conference

September 26, 2023

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals ↗

September 23, 2023

Rocket could launch its medicines sooner, but Intellia is aiming for larger markets.

Via The Motley Fool

Rocket Pharmaceuticals Stock Is Blasting Off, but Here's Why You Should Tread Carefully ↗

September 18, 2023

Its near-term risks are subtle but bigger than their flying stock price might indicate.

Via The Motley Fool

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet ↗

September 15, 2023

Investors are on the hunt for undervalued, under followed and emerging stocks. Retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

Via Benzinga

Dow Turns Lower; KULR Technology Group Shares Plummet ↗

September 13, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones falling 100 points on Wednesday. The Dow traded down 0.29% to 34,545.66 while the NASDAQ rose 0.22% to 13,803.43. The S&P 500,...

Via Benzinga

Topics Stocks

Why Is Rocket Pharmaceuticals (RCKT) Stock Up 35% Today? ↗

September 13, 2023

With Rocket Pharmaceuticals reaching a Phase II agreement with the FDA, RCKT stock soared, though some concerns linger.

Via InvestorPlace

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 13, 2023

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 13, 2023

Via Benzinga

Dow Gains 50 Points; US Crude Oil Inventories Rise ↗

September 13, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 50 points on Wednesday. The Dow traded up 0.16% to 34,701.06 while the NASDAQ rose 0.44% to 13,834.85. The S&P 500,...

Via Benzinga

Topics Stocks

Why Shares of Rocket Pharmaceuticals Are Taking Off on Wednesday ↗

September 13, 2023

The late-stage pharmaceutical company said it had reached an agreement with the Food and Drug Administration regarding a phase 2 trial for a Danon disease therapy.

Via The Motley Fool

What's Going On With Gene Therapy-Focused Rocket Pharmaceuticals Stock Today? ↗

September 13, 2023

On Tuesday, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501

Via Benzinga

Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday ↗

September 13, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 13, 2023

Via Benzinga

GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

September 13, 2023

Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. Rocket Pharmaceuticals shares rose 24.3% to $19.00 in...

Via Benzinga

Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

September 13, 2023

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 13, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!

Via InvestorPlace

Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock

September 13, 2023

From Rocket Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 12, 2023

Via Benzinga

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

September 12, 2023

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease

September 12, 2023

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

September 06, 2023

From Rocket Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Rocket Pharmaceuticals, Inc. - Common Stock (NQ:RCKT)

All News about Rocket Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today